Feasibility of evaluating AI-enabled digital symptom monitoring in metastatic patients with NSCLC receiving pembrolizumab therapy: A German single-arm observational pilot study by Melissa L. Santorelli, Oliver Schmalz, Mathias Hoiczyk, David Heigener, Clemens Schulte, Markus Knott, Petra Hoffknecht, Joonas Vainio, Thomas Burke, Josephine M. Norquist, Sabine Riehl, Alexander Hildner, Lisa Barthuber, Sabine Bohnet

Get full text